These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 2308057)

  • 1. Pharmacokinetics of small unilamellar liposomes and incorporated lonazolac after i.m. administration.
    Naeff R; Pliska V; Weder HG
    J Microencapsul; 1990; 7(1):95-103. PubMed ID: 2308057
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pharmacokinetics of the antirheumatic lonazolac-Ca in humans].
    Huber R; Zech K; Dittmann EC; Lühmann R; Petitet A
    Arzneimittelforschung; 1990 Aug; 40(8):918-25. PubMed ID: 2242085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transsynovial kinetics of lonazolac and its hydroxy metabolite in synovitis patients.
    Deneke J; Luckow V; Guserle R; Pässler HH
    Int J Clin Pharmacol Ther; 1998 Aug; 36(8):418-24. PubMed ID: 9726694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lymphatic delivery and pharmacokinetics of methotrexate after intramuscular injection of differently charged liposome-entrapped methotrexate to rats.
    Kim CK; Han JH
    J Microencapsul; 1995; 12(4):437-46. PubMed ID: 8583318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The in vitro characterisation and biodistribution of some non-ionic surfactant coated liposomes in the rabbit.
    Khattab MA; Farr SJ; Taylor G; Kellaway IW
    J Drug Target; 1995; 3(1):39-49. PubMed ID: 7655819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Synthesis and physico-chemical properties of lonazolac-Ca, a new antiphlogistic/antirheumatic agent].
    Rainer G; Krüger U; Klemm K
    Arzneimittelforschung; 1981; 31(4):649-55. PubMed ID: 6972771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bioavailability of a small unilamellar low-clearance liposomal amikacin formulation after extravascular administration.
    Fielding RM; Moon-McDermott L; Lewis RO
    J Drug Target; 1999; 6(6):415-26. PubMed ID: 10937287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Lonazolac-Ca = Calcium [3-(p-chlorophenyl)-1-phenylpyrazole-4[ -acetate 1 Pharmacological properties of a new antiinflammatory/antirheumatic drug (author's transl)].
    Riedel R
    Arzneimittelforschung; 1981; 31(4):655-65. PubMed ID: 6972772
    [No Abstract]   [Full Text] [Related]  

  • 9. Pharmacokinetics and metabolism of i.m. injected polyenylphosphatidylcholine liposomes.
    Zierenberg O; Betzing H
    Arzneimittelforschung; 1979; 29(3):494-8. PubMed ID: 582734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of gonadotropin-releasing hormone and stimulation of luteinizing hormone secretion after single dose administration of GnRH incorporated into liposomes.
    Schäfer H; Schmidt W; Berger H; Bergfeld J
    Pharmazie; 1987 Oct; 42(10):689-93. PubMed ID: 3325991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single and multiple-dose pharmacokinetics of tepoxalin and its active metabolite after oral administration to rabbits (Oryctolagus cuniculus).
    Pollock CG; Carpenter JW; Koch DE; Hunter RP
    J Vet Pharmacol Ther; 2008 Apr; 31(2):171-4. PubMed ID: 18307510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biodistribution of liposomes after extradural administration in rodents.
    Umbrain V; Alafandy M; Bourgeois P; D'Haese J; Boogaerts JG; Goffinet G; Camu F; Legros FJ
    Br J Anaesth; 1995 Sep; 75(3):311-8. PubMed ID: 7547050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-circulating liposomes of indomethacin in arthritic rats--a biodisposition study.
    Srinath P; Chary MG; Vyas SP; Diwan PV
    Pharm Acta Helv; 2000 Apr; 74(4):399-404. PubMed ID: 10812940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Determination of Lonazolac in blood using liquid chromatography with fluorescence detection and use of this method in a comparison of Lonazolac-Irritren preparations].
    Stehlík P; Hapala J; Cepeláková H
    Cesk Farm; 1991 Mar; 40(1):37-9. PubMed ID: 1878992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Lonazolac-Ca-a non-steroidal antirheumatic agent. Long-term clinical study in chronic polyarthritis].
    Lonauer G; Wagner H; Boerngen U; Goebel KM
    Z Rheumatol; 1981; 40(4):161-4. PubMed ID: 7027681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of an antiphlogistic incorporated in liposomes on experimentally induced inflammation.
    Schramlová J; Blazek K; Otová B; Bartácková M; Hulínská D
    Folia Biol (Praha); 1997; 43(5):195-9. PubMed ID: 9595260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative effects of PEG-containing liposomal formulations on in vivo pharmacokinetics of streptokinase.
    Jin SE; Kim IS; Kim CK
    Arch Pharm Res; 2015 Oct; 38(10):1822-9. PubMed ID: 25851624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics and tissue distribution of zidovudine in rats following intravenous administration of zidovudine myristate loaded liposomes.
    Jin SX; Bi DZ; Wang J; Wang YZ; Hu HG; Deng YH
    Pharmazie; 2005 Nov; 60(11):840-3. PubMed ID: 16320946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Uptake of drug-carrier liposomes by placenta: transplacental delivery of drugs and nutrients.
    Tüzel-Kox SN; Patel HM; Kox WJ
    J Pharmacol Exp Ther; 1995 Jul; 274(1):104-9. PubMed ID: 7616385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aggregation of unilamellar lecithin liposomes induced by cyclosporin.
    Stuhne-Sekalec L; Chudzik J; Stanacev NZ
    J Microencapsul; 1986; 3(3):165-9. PubMed ID: 3508184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.